Main Research and Development Centers
Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S.
Andover, Massachusetts
Combining state-of-the-art R&D and Pfizer Global Supply (PGS) facilities with flexible, multi-product manufacturing capabilities, Andover is a key driver of innovation across our biologics discovery, development, and global clinical and commercial supply efforts.
Bothell, WA
Utilizing advanced laboratories and equipment, researchers in Bothell are dedicated to revolutionizing cancer treatment.
Cambridge, Massachusetts
Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.
Groton, Connecticut
Many of the discoveries and innovations that drive the Pfizer pipeline to new potential occur in the world-class research and development laboratories in Groton.
San Diego, CA
With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.
Pearl River, New York
As the global hub for Pfizer Vaccine Research and Development, our Pearl River colleagues have developed and manufactured vaccines and other medicines for more than a century.
St. Louis, MO
An expansive laboratory and manufacturing space, our colleagues focus on the development of potential new medicines to help prevent or treat diseases and conditions.

Clinical Trials
Learn more about the process of joining a clinical trial and find a trial near you.
Go to Pfizer Clinical Trials Site DetailsRelated Articles
Decoding Tumors: Inside the Spatial Revolution in Cancer Research
Advances in what’s known as spatial transcriptomics have enabled scientists to begin stitching snapshots of cancer cells together.
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises
Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.
Direct Relief and The Pfizer Foundation Expand Support for Community Health Centers on the Front Lines of Infectious Disease Care
This spring, Direct Relief and The Pfizer Foundation announced the third cohort of the Innovation Awards in Community Health.










